The pathogenic role of IL10 gene polymorhisms in type 1 diabetes mellitus

  • N.A. Ivanova Institute of General Pathology and Pathophysiology, Baltijskaya Str. 8, Moscow 125315, Russian Federation
  • Alexey M. Burdennyy Institute of General Pathology and Pathophysiology, Baltijskaya Str. 8, Moscow 125315, Russian Federation; N.M. Emanuel Institute for Biochemical Physics, Russian Academy of Sciences, Kosygina Str. 4, Moscow 119334, Russian Federation https://orcid.org/0000-0002-9398-8075
  • V.I. Loginov Institute of General Pathology and Pathophysiology, Baltijskaya Str. 8, Moscow 125315, Russian Federation; Academician N.P. Bochkov Research Center of Medical Genetics, Moskvorechje Str. 1, Moscow 115478, Russian Federation https://orcid.org/0000-0003-2668-8096
  • T.L. Kuraeva National Medical Research Center for Endocrinology, Dmitriya Uljyanova Str. 11, Moscow 117036, Russian Federation
  • V.V. Nosikov N.M. Emanuel Institute for Biochemical Physics, Russian Academy of Sciences, Kosygina Str. 4, Moscow 119334, Russian Federation
Keywords: type 1 diabetes mellitus, cytokines, IL10 gene, polymorphism

Abstract

Type 1 diabetes mellitus (T1DM) is a multifactorial disease of an autoimmune origin. An important factor in the pathogenesis of T1DM is genetic predisposition characterized by the presence of functional single-nucleotide polymorphisms (SNPs) in the cytokine genes contributing to inflammation. Long-standing, chronic inflammation is considered to result in irreversible destruction of all pancreatic b-cells and may be due to the presence of functional polymorphic markers in genes of inflammation antagonists, such as the interleukin 10 (IL10) gene. Aim. The aim of this study was to determine the frequency of allelic variants in a number of IL10 gene polymorphic markers in residents of Moscow and the Moscow Region with T1DM. Methods. The study includes 366 patients with T1DM with different manifestations and a median duration of 41+5 years and 526 healthy individuals. The groups were gender- and age-matched. Genotypes of the rs1800896, rs1800872, and rs3024505 polymorphic markers of the IL10 gene were determined with real-time PCR on a Real-Time CFX96 Touch amplifier (Bio-Rad, USA) with a qPCRmix-HS ready-mixed PCR kit (Eurogen, Russia) and unique primers and probes. Results. The rs1800896 polymorphic marker of the IL10 gene statistically significantly correlated with increased risk of T1DM (χ2=15.52, OR=1.48, CI95%=1.23-1.79, р=0.0004). Conclusion. The study results complement the information about T1DM mechanisms of origin and pathogenesis. Implementation in practice of the methods for analyzing polymorphic variants of the IL10 gene will allow revealing a predisposition to this disease and/or its progression in patients with autoimmune diseases or in people at risk.

Downloads

Download data is not yet available.
Published
2020-08-21
How to Cite
Ivanova N., Burdennyy A. M., Loginov V., Kuraeva T., Nosikov V. The pathogenic role of IL10 gene polymorhisms in type 1 diabetes mellitus // Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya (Pathological physiology and experimental therapy). 2020. VOL. 64. № 3. PP. 29–33.
Section
Original research